N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Not applicable ClinicalTrials.gov

Long-Covid-19 Alleviation Through Learning Mindfulness Study

Sponsor: Columbia University • ClinicalTrials.gov ID: NCT07140094

Registry updated: 2026-08-31
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

This research is being done to study a mindfulness intervention among people who have symptoms of Post-Acute Sequelae of SARS-CoV-2 infection (PASC), also known as Long COVID. Mindfulness is defined as paying attention to the present moment with non-judgment and acceptance. Here the investigators are studying whether a mindfulness intervention can help reduce stress, reduce Long COVID symptoms, and improve quality of life among people living with Long COVID. The mindfulness intervention is a series of recorded mindfulness sessions, which were created by the study team. People who decide to take part will be randomly assigned to receive the study mindfulness intervention immediately after joining the study or to receive the study mindfulness intervention 8 weeks after joining the study. All participants will continue their usual medical care. Participants will complete online surveys to measure symptoms over time. The study will last 6 months.

Interventions

  • Structured mindfulness intervention (Behavioral)
    The mindfulness intervention is a series of recorded mindfulness sessions, which were created by the study team. The mindfulness recordings are between two and twenty minutes long and are accessed online.

Eligibility criteria

Inclusion Criteria: * Age \> or = 18 * Willing and able to provide informed consent * Access to the internet * Self-reported history of SARS-CoV-2 infection * Current symptoms attributed to PASC by participant or by participant's medical provider; ongoing symptoms that persisted \>= 12 weeks after Covid-19 illness Exclusion Criteria: * Participating in another clinical trial of an intervention for PASC symptoms * Engaged in a structured MBI

Conditions

Long COVID Long Covid19 Post-Acute COVID-19 Post-Acute COVID-19 Syndrome Post-Acute COVID-19 Infection COVID Long-Haul

Locations

  • Columbia University — New York, New York, United States
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record